Henry Li, M.D.
NPI 1831166024 · Hematology & Oncology Physician · Seattle, WA
Enrolled with Medicare as Practitioner - Hematology/Oncology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1831166024
- Entity type
- Individual
- Primary specialty
- Hematology & Oncology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- MD00036807 (WA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
20 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
6,847 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Insertion of Needle Into Vein for Collection of Blood Sample36415 | 1,136 | $9 |
| Complete Blood Cell Count (red Cells, White Blood Cell, Platelets), Automated Test and Automated Differential White Blood Cell Count85025 | 1,091 | $8 |
| Blood Test, Comprehensive Group of Blood Chemicals80053 | 903 | $10 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 643 | $139 |
| Infusion Into a Vein for Therapy, Prevention, Or Diagnosis, 1 Hour Or Less96365 | 565 | $73 |
| Administration of Chemotherapy Into Vein, 1 Hour Or Less96413 | 288 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 45 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Gabapentin | 113 | 22 |
| Anastrozole | 109 | 34 |
| Hydroxyurea | 108 | 31 |
| Tamoxifen Citrate | 71 | 19 |
| Acalabrutinib Maleatebrand: Calquence | 65 | — |
| Prednisone | 62 | 23 |
| Enzalutamidebrand: Xtandi | 61 | — |
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-03-07
- Last updated
- 2012-05-10
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.